Literature DB >> 8739400

Diagnostic validity of basic symptoms.

J Klosterkötter1, H Ebel, F Schultze-Lutter, E M Steinmeyer.   

Abstract

Although the Bonn Scale for the Assessment of Basic Symptoms (BSABS) [13] has come into use in several European countries, its diagnostic validity has not yet been sufficiently examined. That is why we have assessed BSABS items on a sample of 243 consecutive admissions to the Department of Psychiatry at the RWTH University, Aachen, and 79 psychologically healthy persons. Then, a cluster analysis was calculated to identify the empirical item-grouping. Five well-interpretable BSABS subsyndromes were found. In addition, uni- and multivariate analyses were computed to evaluate the diagnostic validity of these subsyndromes. We were able to show that every BSABS subsyndrome separates at least schizophrenic, organic mental and affective disorders from personality, neurotic and substance-induced disorders, as well as from psychological health. Furthermore, the subsyndrome "information processing disturbances" differentiates between schizophrenic and organic mental disorders, on the one hand, and affective disorders, on the other, and additionally, the subsyndrome "interpersonal irritation" between schizophrenics and all other persons examined.

Entities:  

Mesh:

Year:  1996        PMID: 8739400     DOI: 10.1007/bf02189116

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  17 in total

Review 1.  Effect of neuroleptics on positive and negative symptoms and the deficit state.

Authors:  J Angst; H H Stassen; B Woggon
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation.

Authors:  M Birchwood; J Smith; F Macmillan; B Hogg; R Prasad; C Harvey; S Bering
Journal:  Psychol Med       Date:  1989-08       Impact factor: 7.723

3.  A study of negative symptoms in schizophrenia and depression.

Authors:  P Kulhara; R Chadda
Journal:  Compr Psychiatry       Date:  1987 May-Jun       Impact factor: 3.735

4.  Positive or negative symptoms--which are more appropriate as diagnostic criteria for schizophrenia?

Authors:  J Klosterkötter; M Albers; E M Steinmeyer; A Hensen; H Sass
Journal:  Acta Psychiatr Scand       Date:  1995-11       Impact factor: 6.392

5.  [Substrate near-basic disorder or nosologically ambiguous subjective cognitive disorder? Critical analysis of the Frankfurt Complaint Questionnaire by Süllwold].

Authors:  L Teusch
Journal:  Nervenarzt       Date:  1985-05       Impact factor: 1.214

6.  [Uncharacteristic "basic" symptoms in the Frankfurt Complaint Questionnaire and their relation to psychopathologic syndromes].

Authors:  M Rösler; W Bellaire; G Hengesch; H Kiesling-Muck; W Carls
Journal:  Nervenarzt       Date:  1985-05       Impact factor: 1.214

7.  [Basic disorders. A revision with structure-dynamic measures].

Authors:  W Janzarik
Journal:  Nervenarzt       Date:  1983-03       Impact factor: 1.214

Review 8.  Schizophrenia: the characteristic symptoms.

Authors:  N C Andreasen; M Flaum
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

9.  Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication.

Authors:  M I Herz; H V Szymanski; J C Simon
Journal:  Am J Psychiatry       Date:  1982-07       Impact factor: 18.112

Review 10.  [Schizophrenia and age].

Authors:  H Häfner; K Maurer; W Löffler; A Riecher-Rössler
Journal:  Nervenarzt       Date:  1991-09       Impact factor: 1.214

View more
  25 in total

1.  Changes in symptom content from a clinical high-risk state to conversion to psychosis.

Authors:  Catherine Marshall; Yun Lu; Kristina Lyngberg; Stephanie Deighton; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2017-08-03       Impact factor: 2.732

Review 2.  [The crisis of the operational diagnostic approach in psychiatry].

Authors:  M Jäger; K Frasch; T Becker
Journal:  Nervenarzt       Date:  2008-03       Impact factor: 1.214

3.  The concept of psychosis: historical and phenomenological aspects.

Authors:  Martin Bürgy
Journal:  Schizophr Bull       Date:  2008-01-03       Impact factor: 9.306

4.  [The history and phenomenology of the concept of psychosis. A perspective of the Heidelberg school (1913-2008)].

Authors:  M Bürgy
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

Review 5.  Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome.

Authors:  Scott Richard Clark; Klaus Oliver Schubert; Bernhard Theodor Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-10-16       Impact factor: 3.575

6.  The concept of basic symptoms: its scientific and clinical relevance.

Authors:  Frauke Schultze-Lutter; Anastasia Theodoridou
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

7.  Self-Transformation at the Boundary of Religious Conversion and Psychosis.

Authors:  Szabolcs Kéri
Journal:  J Relig Health       Date:  2020-02

8.  Subjective experience of cognitive failures as possible risk factor for negative symptoms of psychosis in the general population.

Authors:  Stefanie Pfeifer; Jim van Os; Manon Hanssen; Philippe Delespaul; Lydia Krabbendam
Journal:  Schizophr Bull       Date:  2008-02-21       Impact factor: 9.306

9.  Christianity and Schizophrenia Redux: An Empirical Study.

Authors:  Szabolcs Kéri; Oguz Kelemen
Journal:  J Relig Health       Date:  2020-02

10.  Study of cenesthesias and body image aberration in schizophrenia.

Authors:  Gaurav Rajender; Krishna Kanwal; Dinesh M Rathore; Deepa Chaudhary
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.